BOREAL GENOMICS INC.

Profile

Company Names

BOREAL GENOMICS INC.

Addresses

2386 EAST MALL., VANCOUVER, A1 V6T1Z3

#302-2386 EAST MALL., VANCOUVER, A1 V6T1Z3

Phone Numbers

6048228268

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$24,499,996.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-09-30 
$17,999,997.00 
$17,999,997.00 
$0.00 
Equity 
1
2010-10-01 
$6,499,999.00 
$6,499,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BROEMELING 
EXECUTIVE OFFICER
BOREAL GENOMICS INC.
DAVID 
 
BROEMLING 
EXECUTIVE OFFICER
BOREAL GENOMICS INC.
CALEY 
 
CASTELEIN 
DIRECTOR
VIEWRAY INC   |  BOREAL GENOMICS INC.   |  VIEWRAY, INC.   |  AERPIO PHARMACEUTICALS, INC.   |  KVP CAPITAL, LP   |  REVELATION KEARNY, LLC   |  AADI BIOSCIENCE, INC.
KEITH 
 
CRANDALL 
DIRECTOR
BOREAL GENOMICS INC.   |  CYTRELLIS BIOSYSTEMS, INC.
KEITH 
 
CRANDELL 
DIRECTOR
ADESTO TECHNOLOGIES CORP   |  UNIVA CORP   |  CRYSTAL IS INC   |  NANOSYS INC   |  CIESPACE CORP   |  908 DEVICES INC.   |  TWIST BIOSCIENCE CORP   |  QUANTERIX CORP   |  BOREAL GENOMICS INC.   |  PIXELEXX SYSTEMS, INC.   |  NANOSYS, INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  ULTIVUE, INC.   |  VIZGEN, INC.
ANDRE 
 
MARZIALI 
EXECUTIVE OFFICER, DIRECTOR
BOREAL GENOMICS INC.
ANDREA 
 
MARZIALI 
EXECUTIVE OFFICER, DIRECTOR
BOREAL GENOMICS INC.
NICHOLAS 
 
NACLERIO 
DIRECTOR
BOREAL GENOMICS INC.   |  ILLUMINA INNOVATION FUND I, L.P.   |  BAEBIES INC.   |  GENOME MEDICAL HOLDING CO   |  SERIMMUNE INC.   |  PATTERN BIOSCIENCE, INC.   |  ILLUMINA INNOVATION FUND II, L.P.   |  MMMLY INC.   |  ILLUMINA INNOVATION FUND III, L.P.
NITIN 
 
SOOD 
EXECUTIVE OFFICER, DIRECTOR
BOREAL GENOMICS INC.
THOMAS 
 
WILLIS 
DIRECTOR, EXECUTIVE OFFICER
MLC DX INC   |  SEQUENTA, INC.   |  BOREAL GENOMICS INC.   |  OSPREYDATA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-30 
2010-12-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#